Prostate Cancer Clinical Trials in Los Angeles, CA

Prostate Cancer Clinical Trials in Los Angeles, CA

View the best 10 prostate cancer medical studies in Los Angeles, California. Access promising new therapies by applying to a Los Angeles-based Prostate Cancer clinical trial.

Trials in Los Angeles, California

Here are the top 10 medical studies for prostate cancer in Los Angeles, California

Image of The Urology Place in San Antonio, United States.

Vanquish System

Procedure

Recruiting1 award
This trial is testing a device called Vanquish that uses steam to treat prostate cancer. It targets men with a specific type of intermediate-risk prostate cancer. The steam heats up and kills the cancer cells in the prostate.
Image of Yale Cancer Center in New Haven, United States.

Radical Prostatectomy +1 More

Procedure

Recruiting1 award6 criteria
This trial compares a new treatment with traditional surgery in men with prostate cancer. The goal is to see if the new treatment can effectively treat cancer while preserving important functions better than surgery. Patients will be followed for several years to assess outcomes. The new treatment is minimally invasive and uses advanced technology to target prostate tissue.
Image of Charles R. Drew University of Medicine and Science in Los Angeles, United States.

Docetaxel

Chemotherapy

Recruiting0 awardsPhase 1 & 2
This trial aims to see if adding green tea and quercetin to standard chemotherapy can help in treating advanced prostate cancer. Researchers will compare this combination to a placebo to understand its effectiveness and safety.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Apalutamide

Antiandrogen

Recruiting2 awardsPhase 3
This trial is testing whether adding apalutamide to standard treatment, with or without targeted radiation therapy, helps patients with prostate cancer that has come back after treatment.
Image of Alaska Urological Institute dba Alaska Clinical Research Center in Anchorage, United States.

Talazoparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial looks at whether adding the drug talazoparib to the drug enzalutamide improves progression-free survival in men with metastatic castration-resistant prostate cancer.
Image of Tower Urology, in Los Angeles, United States.

Debio 4228

Anti-tumor antibiotic

Recruiting1 awardPhase 2
This trial aims to understand how the drug Debio 4228 moves through and affects the body.
Image of START Midwest in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug called NGM831 alone or with other drugs in patients with advanced or spreading solid tumors. The goal is to see if these treatments can help stop the cancer or help the immune system fight it better. One of the drugs being tested has been widely studied and used in various cancers, showing significant improvements in survival rates and being effective in combination with other treatments.
Image of University of Alabama at Birmingham in Birmingham, United States.

Abiraterone

Androgen Deprivation Therapy

Recruiting1 awardPhase 3
This trial is testing whether abemaciclib, when added to abiraterone plus prednisone, can help to treat prostate cancer by prolonging the time before the cancer gets worse.
Image of Clinical Trial Site in La Jolla, United States.

ARV-766

Androgen Receptor Antagonist

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug called ARV-766, alone or with abiraterone, in men with advanced prostate cancer that has spread. The drug works by blocking proteins that help cancer cells grow. Abiraterone is a well-established drug used in the treatment of metastatic castration-resistant prostate cancer, often in combination with other therapies.
Image of University of California, Los Angeles in Los Angeles, United States.

Exercise Therapy

Behavioral Intervention

Recruiting1 awardPhase 2
This trial is studying how regular walking exercises at home affect people with low-risk prostate cancer who are being monitored but not actively treated. Participants will either follow a specific walking routine or continue their usual exercise habits. Researchers aim to see if the walking routine has any impact on prostate cancer indicators.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.